Chest CT Computerized Aided Quantification of PNEUMONIA Lesions in COVID-19 Infection: A Comparison among Three Commercial Software
Authors:
- Roberto GrassiRoberto Grassi
- Salvatore CappabiancaSCSalvatore Cappabianca
- Fabrizio UrraroFUFabrizio Urraro
- Beatrice FeragalliBFBeatrice Feragalli
- Alessandro MontanelliAMAlessandro Montanelli
- Gianluigi PatelliGPGianluigi Patelli
- Vincenza GranataVGVincenza Granata
- Giuliana GiacobbeGGGiuliana Giacobbe
- Gaetano Maria RussoGRGaetano Maria Russo
- Assunta GrilloAGAssunta Grillo
- Angela De LisioALAngela De Lisio
- Cesare PauraCPCesare Paura
Open Access
- 22 September 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (18) , 6914
Abstract
Purpose: To compare different commercial software in the quantification of Pneumonia Lesions in COVID-19 infection and to stratify the patients based on the disease severity using on chest computed tomography (CT) images. Materials and methods: We retrospectively examined 162 patients with confirmed COVID-19 infection by reverse transcriptase-polymerase chain reaction (RT-PCR) test. All cases were evaluated separately by radiologists (visually) and by using three computer software programs: (1) Thoracic VCAR software, GE Healthcare, United States; (2) Myrian, Intrasense, France; (3) InferRead, InferVision Europe, Wiesbaden, Germany. The degree of lesions was visually scored by the radiologist using a score on 5 levels (none, mild, moderate, severe, and critic). The parameters obtained using the computer tools included healthy residual lung parenchyma, ground-glass opacity area, and consolidation volume. Intraclass coefficient (ICC), Spearman correlation analysis, and non-parametric tests were performed. Results: Thoracic VCAR software was not able to perform volumes segmentation in 26/162 (16.0%) cases, Myrian software in 12/162 (7.4%) patients while InferRead software in 61/162 (37.7%) patients. A great variability (ICC ranged for 0.17 to 0.51) was detected among the quantitative measurements of the residual healthy lung parenchyma volume, GGO, and consolidations volumes calculated by different computer tools. The overall radiological severity score was moderately correlated with the residual healthy lung parenchyma volume obtained by ThoracicVCAR or Myrian software, with the GGO area obtained by the ThoracicVCAR tool and with consolidation volume obtained by Myrian software. Quantified volumes by InferRead software had a low correlation with the overall radiological severity score. Conclusions: Computer-aided pneumonia quantification could be an easy and feasible way to stratify COVID-19 cases according to severity; however, a great variability among quantitative measurements provided by computer tools should be considered.Keywords
This publication has 24 references indexed in Scilit:
- Coronavirus Disease 2019 (COVID-19): A Perspective from ChinaRadiology, 2020
- Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19)Radiology, 2020
- CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) PneumoniaRadiology, 2020
- A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19)medRxiv, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Artificial intelligence: Who is responsible for the diagnosis?La radiologia medica, 2020
- Artificial intelligence: a challenge for third millennium radiologistLa radiologia medica, 2019
- Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologistLa radiologia medica, 2017
- Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2013
- CT-quantified emphysema in male heavy smokers: association with lung function declineThorax, 2011